AAGH OTC
America Great Health
1W: +0.0%
1M: -33.3%
3M: +100.0%
YTD: +100.0%
1Y: -66.7%
3Y: -42.9%
5Y: -98.5%
$0.00
+0.00 (+0.00%)
Weekly Expected Move ±49.1%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$4.2M
52W Range0.0001-0.0006
Volume1,001,000
Avg Volume812,193
Beta6.41
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOMike Qingkun Wang
Employees5
SectorHealthcare
IndustryBiotechnology
IPO Date2012-09-25
Websiteaaghus.com
1609 West Valley Boulevard
Alhambra, CA 91803
US
Alhambra, CA 91803
US
626-576-1299
About America Great Health
Operating as a U.S.-based biotechnology company, America Great Health (AAGH) focuses on two primary areas: the research and development of protein and peptide small molecular drugs, and the manufacturing and sale of a diverse portfolio including AI cloud computing-driven diagnostic and medical devices, cell therapies, regenerative medicine, and supplements. The company, which originated as Crown Marketing, adopted the name America Great Health in March 2017. Established in 2013, AAGH's headquarters are located in Alhambra, California.
Recent Insider Trades
No insider trades found